Wednesday, June 24, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 892 of 1,261
  1. US 8337896

    Drug-containing nanoparticles

    Takeda Pharmaceutical Company Limited · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  2. US 8338107

    Method for producing polymers having a preselected activity

    CATALYST ASSETS, LLC · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  3. US 8338102

    Method of diagnosing poor survival prognosis colon cancer using miR-181b

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  4. US 8337831

    Live, oral vaccine for protection against Shigella dysenteriae serotype 1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  5. US 8337832

    Vaccine for protection against Shigella sonnei disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  6. US 8337830

    Yeast-based vaccines as immunotherapy

    The Regents of the University of Colorado · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  7. US 8337853

    Monoclonal antibodies that bind or neutralize dengue virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  8. US 8337848

    Monoclonal antibody for APP

    University College Cardiff Consultants Limited · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  9. US 8337854

    Monoclonal antibodies against dengue and other viruses with deletion in Fc region

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  10. US 8337866

    Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia

    The Regents of the University of California · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  11. US 8337860

    Development of dengue virus vaccine components

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  12. US 8338624

    Isoflavone derivatives and uses thereof

    Medical Research and Infrastructure Fund of Tel-Aviv Sourasky Medical Center · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  13. US 8338462

    1-heterocyclylsulfonyl, 3-aminomethyl, 5- (hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  14. US 8338424

    Guanidine-containing compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  15. US 8338412

    Inhibitors of P38

    Vertex Pharmaceuticals Incorporated · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  16. US 8337813

    Contrast agents

    Northwestern University · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  17. US 8338105

    Method of diagnosing poor survival prognosis colon cancer using miR-203

    The United States of America as represented by the Secretary of the Department of Health and Human Services, National Institute of Health, Office of Technology Tansfer · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  18. US 8338366

    Bioactive FUS1 peptides and nanoparticle-polypeptide complexes

    The Board of Regents of the University of Texas System · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  19. US 8338106

    Method of diagnosing poor survival prognosis colon cancer using miR-29a

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  20. US 8338103

    Method of diagnosing poor survival prognosis colon cancer using miR-106a

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  21. US 8338597

    Pyridones useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  22. US 8338569

    FGFR extracellular domain acidic region muteins

    Five Prime Therapeutics, Inc. · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  23. US 8338484

    N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  24. US 8338622

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.